Product Information

DROXIDOPA 300 MG CAPSULE is a generic product labeled by CivicaScript LLC, priced at $1.7798 per EA under NDC 82249055490. Its NADAC has been published 76 times since Jun 11, 2025.

FDA first approved this application on Feb 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DROXIDOPA 300 MG CAPSULE

Droxidopa
$1.7798per EA

Strength

300 mg/1

Manufacturer

CivicaScript LLC

NDC

82249055490

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DROXIDOPA

Approval Type

Generic (ANDA)

FDA Application

ANDA213911

FDA Approved

2/18/2021

TE Code

AB

On Market Since

3/3/2025

Pharmacological Classes

Catecholamines
Increased Blood Pressure

Price Statistics

The NADAC for DROXIDOPA 300 MG CAPSULE has been published 76 times since Jun 11, 2025, and over the history we have for it it has declined 21.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7798 per EA
All-time high$2.8151 (Jun 10, 2026)
All-time low$1.7798 (Nov 18, 2026)
52-week high$2.8151
52-week low$1.7798
Median price$2.4007
Average price$2.3983
Largest weekly change-14.0% (Sep 23, 2026)
Weeks tracked76
Tracking sinceJun 11, 2025

Price History

1W

-3.5%

1M

-3.5%

3M

-17.0%

6M

-36.8%

1Y

-27.5%

3Y

N/A

5Y

N/A

All

-21.6%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DROXIDOPA 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 300 MG CAPSULE, manufactured by CivicaScript LLC, is $1.7798 per EA (NDC 82249055490), effective Nov 18, 2026.

How has the price of DROXIDOPA 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DROXIDOPA 300 MG CAPSULE has declined 21.6%. It has been tracked across 76 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for DROXIDOPA 300 MG CAPSULE?

Since Jun 11, 2025, the NADAC for DROXIDOPA 300 MG CAPSULE has ranged from a low of $1.7798 (Nov 18, 2026) to a high of $2.8151 (Jun 10, 2026), with a median of $2.4007 per EA.

Are there cheaper alternatives to DROXIDOPA 300 MG CAPSULE?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DROXIDOPA 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures DROXIDOPA 300 MG CAPSULE?

DROXIDOPA 300 MG CAPSULE (NDC 82249055490) is labeled by CivicaScript LLC, and CMS classifies it as a generic product.